MeVis Medical Solutions AG (ETR:M3V)
Germany · Delayed Price · Currency is EUR 23.80
0.00 (0.00%)
Aug 26, 2026, 5:35 PM CET
ETR:M3V Financials Overview
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 15.48 | 16.06 | 16.97 | 17.34 | 18.76 | 16.21 |
Revenue Growth | -3.60% | -5.36% | -2.14% | -7.57% | 15.71% | -5.35% |
Gross Profit Gross Profit Growth | 3.13 | 4.88 | 6.43 | 7 | 8.59 | 6.92 |
Operating Income Operating Income Growth | 0.65 | 2.32 | 4 | 4.86 | 6.47 | 5.02 |
Net Income Net Income Growth | 1.38 | 3.17 | 4.56 | 4.92 | 7.79 | 4.55 |
Earnings Per Share EPS Growth | 0.76 | 1.74 | 2.51 | 2.70 | 4.28 | 2.50 |
EPS Growth | -56.27% | -30.58% | -7.29% | -36.84% | 71.35% | -20.31% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
United States of America United States of America Growth | 12.59 | 13.46 | 13.04 | 14.44 | 12.2 |
Europe Europe Growth | 3.47 | 3.52 | 4.3 | 4.32 | 4.02 |
Total Total Growth | 16.06 | 16.97 | 17.34 | 18.76 | 16.21 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Cash (Debt) Net Cash Growth | 3.65 | 6.52 | 6.53 | 7.74 | 9.32 | 7.62 |
Net Cash Growth | -44.06% | -0.06% | -15.70% | -16.91% | 22.30% | 92.76% |
Net Cash Per Share Net Cash Per Share Growth | 2.01 | 3.58 | 3.59 | 4.25 | 5.12 | 4.19 |
Cash & Investments Cash & Investments Growth | 3.65 | 6.52 | 6.53 | 7.74 | 9.32 | 7.62 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 3.88 | 3.15 | 5.85 | 4.86 | 9.13 |
Capital Expenditures CapEx Growth | - | -0.14 | -0.3 | -0.08 | -0.13 | -0.05 |
Free Cash Flow Free Cash Flow Growth | - | 3.74 | 2.84 | 5.77 | 4.72 | 9.08 |
Free Cash Flow Growth | - | 31.44% | -50.74% | 22.23% | -47.97% | 225.78% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 20.24% | 30.38% | 37.91% | 40.38% | 45.80% | 42.70% |
Operating Margin | 4.18% | 14.44% | 23.58% | 28.05% | 34.46% | 30.94% |
Pretax Margin | 9.56% | 20.42% | 27.62% | 29.03% | 41.98% | 28.56% |
Profit Margin | 8.94% | 19.71% | 26.87% | 28.37% | 41.52% | 28.04% |
FCF Margin | - | 23.28% | 16.76% | 33.30% | 25.18% | 56.00% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 |
Dividend Per Share Dividend Per Share Growth | 1.130 | 1.130 | 1.130 | 0.950 |
Dividend Per Share Growth | 0% | 0% | 18.95% | - |
Dividend Yield | 4.71% | 4.73% | 5.29% | 3.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 31.29 | 14.26 | 9.18 | 10.51 | 7.99 | 13.05 |
Forward PE | - | 16.98 | 16.98 | 16.98 | 16.98 | 16.98 |
P/FCF Ratio | 11.59 | 12.07 | 14.72 | 8.95 | 13.18 | 6.53 |
PS Ratio | 2.80 | 2.81 | 2.47 | 2.98 | 3.32 | 3.66 |